CDC -Prevention of the development of sars-cov-2 (covid-19) disease by prophylactic administration of emtricitabine / tenofovir disoproxil and hydroxychloroquine in high-risk healthcare personnel: randomized clinical trial,
INDEPENDENT CLINICAL TRIAL
Clinical trial information
- Promoter: NATIONAL AIDS PLAN
- Phase: III
- Execution start: 07/04/2020
- End of execution: 07/04/2021
- PI: LEOPOLDO MUÑOZ MEDINA